EMPROVON Trademark

Trademark Overview

On Monday, August 24, 2020, a trademark application was filed for EMPROVON with the United States Patent and Trademark Office. The USPTO has given the EMPROVON trademark a serial number of 90133400. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, August 29, 2023. This trademark is owned by Amneal Pharmaceuticals LLC. The EMPROVON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of neurological disorders
emprovon

General Information

Serial Number90133400
Word MarkEMPROVON
Filing DateMonday, August 24, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, August 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmneal Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Wednesday, August 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 29, 2023SOU EXTENSION 5 GRANTED
Wednesday, August 23, 2023SOU EXTENSION 5 FILED
Tuesday, August 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023SOU EXTENSION 4 GRANTED
Wednesday, February 22, 2023SOU EXTENSION 4 FILED
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 23, 2022SOU EXTENSION 3 FILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 31, 2021SOU EXTENSION 1 GRANTED
Tuesday, August 31, 2021SOU EXTENSION 1 FILED
Tuesday, August 31, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 29, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 29, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 19, 2020ASSIGNED TO EXAMINER
Saturday, September 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 27, 2020NEW APPLICATION ENTERED

Related Keywords

emprovon disorders neurological treatment pharmaceuticals